Back to Search
Start Over
Predictive factors for recovery time in patients suffering from severe OHSS.
- Source :
-
Reproductive biology and endocrinology : RB&E [Reprod Biol Endocrinol] 2014 Jul 05; Vol. 12, pp. 59. Date of Electronic Publication: 2014 Jul 05. - Publication Year :
- 2014
-
Abstract
- Background: To evaluate predictive factors for recovery time from severe ovarian hyperstimulation syndrome (OHSS).<br />Methods: In a retrospective cohort study, 201 women who were hospitalized for severe OHSS were included. Patients with recurrent OHSS were excluded. All the patients received standardized treatment including intravenous hydration, plasma volume expansion, human albumin, furosemid, subcutaneous heparin, and paracentesis if necessary. The main outcome parameter was recovery time from OHSS. Recovery was defined if a morning hematocrit <40%, rebalance of electrolytes, and serum creatinine <1 mg/dL were reached during the standardized therapy and the patient had not suffered from abdominal pain and discomfort at least for one day without any OHSS-specific infusions or medications.<br />Results: Pregnant patients (n=80, 39.8%) revealed a longer median duration until recovery than non-pregnant patients (n=121, 60.2%; 10 days, IQR 7-13, vs. 8 days, IQR 6-10, respectively; p=0.001). In a generalized linear model, presence of polycystic ovary syndrome before controlled ovarian hyperstimulation (beta=0.3342 +/- 0.1335, p=0.012) and use of hCG for ovulation induction (beta=0.222 +/- 0.1389, p=0.048) were associated with a longer recovery time in pregnant patients. In non-pregnant patients, none of the tested factors was associated with recovery time.<br />Conclusions: Pregnant patients with severe OHSS needed a significantly longer recovery time than non-pregnant patients. In pregnant patients, presence of polycystic ovary syndrome and ovulation induction with hCG were associated with longer recovery times.
- Subjects :
- Abdominal Pain etiology
Abdominal Pain prevention & control
Adult
Austria epidemiology
Chorionic Gonadotropin adverse effects
Chorionic Gonadotropin genetics
Cohort Studies
Combined Modality Therapy
Female
Fertilization in Vitro adverse effects
Hematocrit
Hospitals, University
Humans
Length of Stay
Ovarian Hyperstimulation Syndrome complications
Ovarian Hyperstimulation Syndrome epidemiology
Ovarian Hyperstimulation Syndrome physiopathology
Ovulation Induction adverse effects
Polycystic Ovary Syndrome complications
Pregnancy
Pregnancy Complications blood
Pregnancy Complications epidemiology
Pregnancy Complications physiopathology
Recombinant Proteins adverse effects
Retrospective Studies
Risk Factors
Severity of Illness Index
Models, Biological
Ovarian Hyperstimulation Syndrome therapy
Pregnancy Complications therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1477-7827
- Volume :
- 12
- Database :
- MEDLINE
- Journal :
- Reproductive biology and endocrinology : RB&E
- Publication Type :
- Academic Journal
- Accession number :
- 24996451
- Full Text :
- https://doi.org/10.1186/1477-7827-12-59